Author:
Pereira Andreia Penso,Macedo João,Afonso Ana,Laureano Raul M. S.,de Lima Neto Fernando Buarque
Abstract
AbstractThe success of screening programs depends to a large extent on the adherence of the target population, so it is therefore of fundamental importance to develop computer simulation models that make it possible to understand the factors that correlate with this adherence, as well as to identify population groups with low adherence to define public health strategies that promote behavioral change. Our aim is to demonstrate that it is possible to simulate screening adherence behavior using computer simulations. Three versions of an agent-based model are presented using different methods to determine the agent’s individual decision to adhere to screening: (a) logistic regression; (b) fuzzy logic components and (c) a combination of the previous. All versions were based on real data from 271,867 calls for diabetic retinopathy screening. The results obtained are statistically very close to the real ones, which allows us to conclude that despite having a high degree of abstraction from the real data, the simulations are very valid and useful as a tool to support decisions in health planning, while evaluating multiple scenarios and accounting for emergent behavior.
Funder
ISCTE – Instituto Universitário de Lisboa
FCT - Fundação para a Ciência e Tecnologia, I.P
FCT - Fundação para a Ciência e Tecnologia, I.P.
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Fernandes, A.G., Ferraz, A.N., Brant, R. et al. Diabetic retinopathy screening and treatment through the Brazilian National Health Insurance. Sci. Rep. 12, 13941 https://doi.org/10.1038/s41598-022-18054-6 (2022).
2. World Health Organization. Prevention of Blindness from Diabetes Mellitus. Accessed 05 Aug 2021 (2005).
3. World Health Organization/International Foundation Europe. The Saint Vincent declaration on diabetes care and research in Europe. Diabet. Med. 1990 (1989).
4. Javitt, J. et al. Preventive eye care in people with diabetes is cost-saving to de Federal-Government: Implications for health-care reform. Diabetes Care 17(8), 909–917 (1994).
5. Palmer, A. J. et al. The cost-effectiveness of different management strategies for type I diabetes: A Swiss perspective. Diabetologia 43, 13–26 (2000).